The latest market report published by Credence Research, Inc. “Tuberculosis Diagnostics Market - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025,” the global tuberculosis diagnostics market was valued at US$ 2,220.9 Mn in 2016, and is expected to reach US$ 3,326.9 Mn by 2025 expanding at a CAGR of 4.5 % from 2017 to 2025.
Market Insights
According to World Health organization in 2015 the MDR-TB reported cases were 480,000. The tuberculosis diagnostics kit has undergone tremendous technological advancement to give better accuracy, quick results, and available at low cost. For the purpose of this study, the global tuberculosis diagnostics market is segmented into test types which includes radiographic methods, laboratory methods, nucleic acid testing, phage assay, cytokine detection test, detection of drug resistance, and Mantoux test.
Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/tuberculosis-diagnostics-market
In base year 2016, laboratory methods are leading the types segment due to rising prevalence of tuberculosis, easy collection of specimen sample and available at low cost. Nucleic acid testing, cytokine detection test segment is anticipated to register faster growth in the test types segment throughout the forecast period 2017-2025, as it is providing greater accuracy and requires less incubation period for the interpretation of the results. In 2016 Asia Pacific region dominated the tuberculosis diagnostics market due to factors such as large patient pool suffering with tuberculosis, government and non-government initiatives to eradicate tuberculosis and high disposable income in these regions. North America will register fastest growth throughout the forecast period 2017-2025, mainly due to factors such as rising public awareness regarding contagious diseases, advanced healthcare infrastructure and affordable reimbursement policies.
The tuberculosis diagnostics market is technologically driven and includes major players such as Thermo Fisher Scientific Corporation, Alere Inc., Abbott Laboratories, and Becton Dickinson and Company, among others are few market leaders in tuberculosis diagnostics market and compete to augment their foothold in the market.
The key players profiled in this report are Abbott laboratories, Alere Inc., Becton Dickinson and Company, bioMérieux SA, Cepheid Inc., Epistem plc, F.Hoffman La Roche Ltd., Hain Lifescience GmbH, Hologic Corporation, Thermo Fisher Scientific, Inc. and QIAGEN.
Key Market Movements:
- Higher prevalence of tuberculosis and MDR-TB
- Technological advancement in the tuberculosis diagnostics market providing accuracy and quick result
- Increasing government and non-government initiatives to eradicate tuberculosis
- Affordable reimbursement policies
You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/58571
Report Scope by Segments
By Test Type
- Radiographic Methods
- Laboratory Methods
- Smear Microscopy
- Culture Based Test
- Nucleic Acid Testing
- Phage Assay
- Cytokine Detection Test
- Detection Of Drug Resistance
- Mantoux Test
By Geography Segment
- North America (U.S., Rest of North America)
- Europe (U.K., Germany, France, Rest of Europe)
- Asia Pacific (China, Japan, India, Rest of Asia Pacific)
- Rest of the World (Middle East & Africa, Latin America)
Find more research reports on Biotechnology Industry, by Credence Research
No comments:
Post a Comment